Article
New Orleans—Patient adherence to prostaglandin analogue or prostamide therapy for glaucoma is high but not perfect. There are still opportunities to improve adherence to therapy with these drugs, according to Jacob Wilensky, MD.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.